Health & Medicine
Bioprinting a 3D liver-like device to detoxify the blood
10 May 2014
The device, which is designed to be used outside the body , much like dialysis, uses nanoparticles to trap pore-forming toxins that can damage cellular membranes and are a key factor in illnesses that result from animal bites and stings, and bacterial infections
Eczema may reduce risk of skin cancer
07 May 2014
The immune response triggered by eczema could help prevent tumour formation by shedding potentially cancerous cells from the skin
First case of MERS detected in US
03 May 2014
10-year study shows 'Lethal Factor' could be X-factor for new anthrax vaccine
03 May 2014
Researchers have identified a section of the anthrax toxin Lethal Factor that could help produce a more effective vaccine
Estimating baby’s size gets more precise
30 Apr 2014
Today's statin users consume more calories and fat, and weigh more, than their predecessors
29 Apr 2014
People who take statin drugs to lower their cholesterol appear to have developed a false sense of security that could lead to heart disease and other obesity-related illnesses.
HIV gets deadlier: virus rooted in America, not Africa
29 Apr 2014
Apart from shedding fresh light on the origins of the deadly virus, which has its roots in the US, rather than Africa, new research has found HIV adapting itself to human immune systems
Study suggests more patients with emphysema could benefit from surgery
By By Francesca Davenport | 26 Apr 2014
Skin layer grown in lab could replace animal testing
26 Apr 2014
The new epidermis, grown from human pluripotent stem cells, offers a cost-effective alternative lab model for testing drugs and cosmetics
Greater investment needed to check malaria: WHO
25 Apr 2014
New pain relief targets discovered
24 Apr 2014
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
